Cephalexin
Product Images NDC 42254-338

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 42254-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mjbivjb (A00e07e9 2c16 4d3e Bb63 6fd2b05fe1b7 01)

FDA Label Image

Xcfftggg (A00e07e9 2c16 4d3e Bb63 6fd2b05fe1b7 02)

Xcfftggg (A00e07e9 2c16 4d3e Bb63 6fd2b05fe1b7 02)
Karalex Pharma, LLC is a pharmaceutical company.*
FDA Label Image

Cephalexin 125mg/5ml (A00e07e9 2c16 4d3e Bb63 6fd2b05fe1b7 03)

Cephalexin 125mg/5ml (A00e07e9 2c16 4d3e Bb63 6fd2b05fe1b7 03)
This is a package label for Cephalexin 125mg/5ml, which is an oral suspension made by Hospira Healthcare India Pvt. Ltd. It contains information about the product such as its ID, composition, and storage conditions. It indicates that it is a prescription-only medicine and provides the name of the Physician Partner. It also provides the National Drug Code (NDC) and the RX number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.